Evidence map›Paper›PMID 40286438›Full record

Trial reportThe Journal of urology2025

Acoustic Enhancer Microbubble Cavitation: A Randomized Clinical Trial Evaluating the Safety and Efficacy of a Novel Treatment for Urolithiasis.

Wesley A Mayer, Thomas Chi, Scott Wiener, Christopher H Cantrill, Julio G Davalos, Hemendra N Shah, Marshall L Stoller

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Wesley A MayerScott Department of Urology, Baylor College of Medicine, Houston, Texas.
Thomas ChiDepartment of Urology, University of California, San Francisco, San Francisco, California.
Scott WienerDepartment of Urology, SUNY Upstate Medical University, Syracuse, New York.
Christopher H CantrillUrology San Antonio, San Antonio, Texas.
Julio G DavalosChesapeake Urology Associates, Hanover, Maryland.
Hemendra N ShahDesai Sethi Urology Institute, University of Miami, Miller School of Medicine, Miami, Florida.
Marshall L StollerDepartment of Urology, University of California, San Francisco, San Francisco, California.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe efficacy of ureteroscopy to treat urinary stones is often less than 60%. Acoustic Enhancer is an investigational device of microparticles with a tag designed with an affinity for calcium. We evaluated safety and efficacy of ureteroscopic laser lithotripsy with and without Acoustic Enhancer Microbubble Cavitation in a randomized clinical trial. MATERIALS AND

methodsPatients with urolithiasis were randomized to ureteroscopic laser lithotripsy with or without Acoustic Enhancer. The end points were the proportion of patients without residual fragments ≥ 2 mm on CT 30 days post procedure (fragment-free rate) and adverse events (AEs).

resultsThere were 103 and 93 patients in the investigational and control groups, respectively. There was no statistical superiority between the 2 groups. The fragment-free rate was 41% and 47% in the investigational and control groups, respectively (

conclusionsAlthough laser lithotripsy with microbubble cavitation did not increase efficacy, it was associated with significantly fewer AEs. Efficacy of microbubble cavitation may depend on laser power used. The low efficacy and high rates of AEs with ureteroscopy highlight the need for novel management approaches for urinary stones.

Indexed as

Lithotripsy, LaserMicrobubblesUreteroscopyUrolithiasisAdultAgedFemaleHumansMaleMiddle AgedTreatment Outcomekidney stoneslaser lithotripsymicrobubblesureteral stonesureteroscopy

Identifiers

PMID40286438
PMCPMC12708043

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.